We then filtered the candidates through a list of proteins derived from proteomic profiling of three different GBM cell lines, and further narrowed down SEPT9, SEPT2, WEE1, RPN2, and others as the final candidates (Fig. 1). This evidence concerns the gene SEPTIN9 and glioblastoma.